Skip to main content
Top
Published in: BMC Neurology 1/2015

Open Access 01-12-2015 | Research article

Analysis of risk factors for medication-overuse headache relapse: a clinic-based study in China

Authors: Zhihui Yan, Yuan Chen, Chunfu Chen, Congcong Li, Xiaojun Diao

Published in: BMC Neurology | Issue 1/2015

Login to get access

Abstract

Background

Medication overuse headache (MOH) is the third most prevalent headache type after migraine and tension-type headache. A large number of studies on the long-term prognosis have shown that MOH has a high relapse rate after treatment. Although MOH relapse-related risk factors have been reported, no related research has been performed in China. Therefore, the purpose of this study was to analyze and evaluate the risk factors for MOH relapse in China.

Methods

Eighty-six out-patients of Shandong Provincial Hospital who were initially diagnosed with MOH, and who had successful withdrawal treatment within 2 months, were chosen from March 2012 to July 2013. All subjects were followed up by the investigators of this study. Of the 86 subjects, 27 who had relapsed were compared with 59 who had not relapsed (i.e. the controls). Based on a standardized questionnaire, a database was created (with Microsoft Excel 2010). The data, which included 38 indexes, were analyzed by univariate analysis with chi-square test, Fisher’s exact test, t-test, or paired rank test. The statistically correlated (P < 0.05) variables were chosen as the independent variables, thereby enabling the calculation of the non-conditional multivariate stepwise logistic regression.

Results

The independent risk factors for medication-overuse headache relapse were determined as headache frequency before drug withdrawal, duration of primary headache, and headache frequency after drug withdrawal.

Conclusion

Headache frequency before drug withdrawal, duration of primary headache, and headache frequency after drug withdrawal may be the independent risk factors for MOH relapse in China.
Literature
1.
go back to reference Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808.
2.
go back to reference Bahra A, Walsh M, Menon S. Does chronic daily headache arise de novo in association with regular use of analgesics? Headache. 2003;43(3):179–90.CrossRefPubMed Bahra A, Walsh M, Menon S. Does chronic daily headache arise de novo in association with regular use of analgesics? Headache. 2003;43(3):179–90.CrossRefPubMed
3.
go back to reference Jonsson P, Hedenrud T, Linde M. Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia. 2011;31:1015–22.CrossRefPubMed Jonsson P, Hedenrud T, Linde M. Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia. 2011;31:1015–22.CrossRefPubMed
4.
go back to reference Obermann M, Bartsch T, Katsarava Z. Medication overuse headache. Expert Opin Drug Saf. 2006;5(1):49–56.CrossRefPubMed Obermann M, Bartsch T, Katsarava Z. Medication overuse headache. Expert Opin Drug Saf. 2006;5(1):49–56.CrossRefPubMed
5.
go back to reference Dong Z, Chen X, Steiner TJ, Hou L, Di H, He M, et al. Medication-overuse headache in China: Clinical profile, and an evaluation of the ICHD-3 beta diagnostic criteria. Cephalalgia. 2015;35:644–51.CrossRefPubMed Dong Z, Chen X, Steiner TJ, Hou L, Di H, He M, et al. Medication-overuse headache in China: Clinical profile, and an evaluation of the ICHD-3 beta diagnostic criteria. Cephalalgia. 2015;35:644–51.CrossRefPubMed
6.
go back to reference Rossi P, Jensen R, Nappi G, Allena M, COMOESTAS Consortium. Anarrative review on the management of medication overuse headache: the steep road from experience to evidence. J Headache Pain. 2009;10(6):407–17.CrossRefPubMedPubMedCentral Rossi P, Jensen R, Nappi G, Allena M, COMOESTAS Consortium. Anarrative review on the management of medication overuse headache: the steep road from experience to evidence. J Headache Pain. 2009;10(6):407–17.CrossRefPubMedPubMedCentral
7.
go back to reference Tepper SJ. Medication-overuse headache. Continuum. 2012;18(4):807–22.PubMed Tepper SJ. Medication-overuse headache. Continuum. 2012;18(4):807–22.PubMed
8.
go back to reference Zebenholzer K, Thamer M, Wöber C. Quality of life, depression, and anxiety 6 months after inpatient withdrawal in patients with medication overuse headache: an observational study. Clin J Pain. 2012;28(4):284–90.CrossRefPubMed Zebenholzer K, Thamer M, Wöber C. Quality of life, depression, and anxiety 6 months after inpatient withdrawal in patients with medication overuse headache: an observational study. Clin J Pain. 2012;28(4):284–90.CrossRefPubMed
9.
go back to reference Evers S, Marziniak M. Clinical features, pathophysiology and treatment of medication-overuse headache. Lancet Neurol. 2010;9(4):391–401.CrossRefPubMed Evers S, Marziniak M. Clinical features, pathophysiology and treatment of medication-overuse headache. Lancet Neurol. 2010;9(4):391–401.CrossRefPubMed
10.
go back to reference Zidverc-Trajkovic J, Pekmezovic T, Jovanovic Z, Pavlovic A, Mijajlovic M, Radojicic A, et al. Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up. Cephalalgia. 2007;27(11):1219–25.CrossRefPubMed Zidverc-Trajkovic J, Pekmezovic T, Jovanovic Z, Pavlovic A, Mijajlovic M, Radojicic A, et al. Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up. Cephalalgia. 2007;27(11):1219–25.CrossRefPubMed
11.
go back to reference Rossi P, Faroni JV, Nappi G. Medication overuse headache: predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study. Cephalalgia. 2008;28(11):1196–200.CrossRefPubMed Rossi P, Faroni JV, Nappi G. Medication overuse headache: predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study. Cephalalgia. 2008;28(11):1196–200.CrossRefPubMed
12.
go back to reference Sances G, Ghiotto N, Galli F, Guaschino E, Rezzani C, Guidetti V, et al. Risk factors in medication-overuse headache: a 1-year follow-up study (care II protocol). Cephalalgia. 2010;30(3):329–36.PubMed Sances G, Ghiotto N, Galli F, Guaschino E, Rezzani C, Guidetti V, et al. Risk factors in medication-overuse headache: a 1-year follow-up study (care II protocol). Cephalalgia. 2010;30(3):329–36.PubMed
13.
go back to reference Radat F, Creac'h C, Swendsen JD, Lafittau M, Irachabal S, Dousset V, et al. Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia. 2005;25(7):519–22.CrossRefPubMed Radat F, Creac'h C, Swendsen JD, Lafittau M, Irachabal S, Dousset V, et al. Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia. 2005;25(7):519–22.CrossRefPubMed
14.
go back to reference Da Silva AN, Lake 3rd AE. Clinical aspects of medication overuse headaches. Headache. 2014;54(1):211–7.CrossRefPubMed Da Silva AN, Lake 3rd AE. Clinical aspects of medication overuse headaches. Headache. 2014;54(1):211–7.CrossRefPubMed
15.
go back to reference Ferrari A, Leone S, Vergoni AV, Bertolini A, Sances G, Coccia CP, et al. Similarities and differences between chronic migraine and episodic migraine. Headache. 2007;47(1):65–72.CrossRefPubMed Ferrari A, Leone S, Vergoni AV, Bertolini A, Sances G, Coccia CP, et al. Similarities and differences between chronic migraine and episodic migraine. Headache. 2007;47(1):65–72.CrossRefPubMed
16.
go back to reference Russell MB, Lundqvist C. Prevention and management of medication overuse headache. Curr Opin Neurol. 2012;25(3):290–5.CrossRefPubMed Russell MB, Lundqvist C. Prevention and management of medication overuse headache. Curr Opin Neurol. 2012;25(3):290–5.CrossRefPubMed
18.
go back to reference Farinelli I, Dionisi I, Martelletti P. Rehabilitating chronic migraine complicated by medication overuse headaches: how can we prevent migraine relapse? Intern Emerg Med. 2011;6(1):23–8.CrossRefPubMed Farinelli I, Dionisi I, Martelletti P. Rehabilitating chronic migraine complicated by medication overuse headaches: how can we prevent migraine relapse? Intern Emerg Med. 2011;6(1):23–8.CrossRefPubMed
19.
go back to reference Grande RB, Aaseth K, Benth JŠ, Lundqvist C, Russell MB. Reduction in medication-overuse headache after short information. The Akershus study of chronic headache. Eur J of Neurol. 2011;18(1):129–37.CrossRef Grande RB, Aaseth K, Benth JŠ, Lundqvist C, Russell MB. Reduction in medication-overuse headache after short information. The Akershus study of chronic headache. Eur J of Neurol. 2011;18(1):129–37.CrossRef
Metadata
Title
Analysis of risk factors for medication-overuse headache relapse: a clinic-based study in China
Authors
Zhihui Yan
Yuan Chen
Chunfu Chen
Congcong Li
Xiaojun Diao
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2015
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-015-0422-1

Other articles of this Issue 1/2015

BMC Neurology 1/2015 Go to the issue